Although it is reported that PLK2 is highly expressed in MM and facilitates tumor cell vitality by inhibiting KIRA8 induced CHOP mediated apoptosis (81), more studies have showed PLK2 acts as a tumor suppressor in hematological neoplasma. Here, PLK2 is linked to Miyoshi myopathy.